Ligand Pharm (NQ: LGND )
108.75
+0.00
(+0.00%)
Streaming Delayed Price
Updated: 1:42 PM EDT, Jul 30, 2024
Add to My Watchlist
All News about Ligand Pharm
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240723930890/en/1990362/5/New_Ligand_Logo.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240709161607_5-best-short-term-stocks-to-consider-investing-in.jpg)
![](https://mms.businesswire.com/media/20240706652097/en/1990362/5/New_Ligand_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Ligand Pharmaceuticals's Earnings: A Preview
February 26, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/ca940278-cc18-4a3f-93b7-d8a034c998c9/small/lifecore-corporate-logo-2c-png.png)
![](https://mms.businesswire.com/media/20240627518993/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240618130919/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240523216667/en/1990362/5/New_Ligand_Logo.jpg)
![](https://g.foolcdn.com/editorial/images/778043/young-woman-holding-thumbs-up.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240507633610/en/2123419/5/logo.jpg)
![](https://mms.businesswire.com/media/20240507973195/en/2122485/5/Ligand_full_color_logo_FINAL.jpg)
![](https://cdn.pixabay.com/photo/2017/08/30/07/56/money-2696228_960_720.jpg)
![](https://mms.businesswire.com/media/20240423025889/en/2106309/5/logo.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/small-cap-1600-1024x576.png)
![](https://mms.businesswire.com/media/20240408525422/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240403857451/en/2087841/22/Scott_Plesha_CEO_Pelthos_Therapeutics.jpg)
![](https://mms.businesswire.com/media/20240305561022/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240304017350/en/1990362/5/New_Ligand_Logo.jpg)
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2024/02/27/image38.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/27/image14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 27, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240227868201/en/1990362/5/New_Ligand_Logo.jpg)
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.